David Playford
Overview
Explore the profile of David Playford including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
813
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Playford D, Ihdayhid A, Guilbert-Wright P
Heart Lung Circ
. 2025 Jan;
34(2):162-172.
PMID: 39824664
Background: Untreated severe heart valve disease (HVD) is associated with premature mortality. Research shows low population awareness of when to seek assessment and low focus on cardiac auscultation by physicians...
2.
Playford E, Stewart S, Hoyne G, Strange G, Dwivedi G, Hamilton-Craig C, et al.
Am Heart J Plus
. 2025 Jan;
49:100493.
PMID: 39760104
Background: There is limited data showing the predictive accuracy of traditional cardiovascular risk scores (CVRS) to predict asymptomatic coronary artery disease (CAD) determined by coronary computed tomography angiography (CCTA). Methods:...
3.
Rowe S, Paratz E, Fahy L, Janssens K, Spencer L, DAmbrosio P, et al.
JACC Adv
. 2025 Jan;
4(1):101444.
PMID: 39759435
Background: In patients with preserved left ventricular ejection fraction (LVEF), small ventricular size has been associated with reduced functional capacity, but its impact on clinical outcomes is unclear. Objectives: The...
4.
Playford D, Stewart S, Harris S, Scalia G, Celermajer D, Thomas L, et al.
Heart
. 2024 Dec;
111(7):327-334.
PMID: 39706686
Background: Although the prognostic implications of severe mitral regurgitation (MR) are well recognised, they are less clear in moderate MR. We therefore explored the prognostic impact of both moderate and...
5.
Strange G, Feneley M, Prior D, Muller D, Venkataraman P, Situ Y, et al.
Am Heart J Plus
. 2024 Dec;
48:100485.
PMID: 39687290
Many severe aortic stenosis (AS) cases are undetected and/or not considered for potentially life-saving treatment, with a persistent male-bias reported among those undergoing aortic valve replacement (AVR). We evaluated the...
6.
Ratwatte S, Playford D, Strange G, Celermajer D, Stewart S
Open Heart
. 2024 Dec;
11(2.
PMID: 39627022
Aims: Pulmonary hypertension (PHT) appears to be very common in heart failure with preserved ejection fraction but details on its prevalence, severity and prognostic implications have not been well defined....
7.
Moonen A, Celermajer D, Ng M, Strange G, Playford D, Stewart S
Open Heart
. 2024 Oct;
11(2).
PMID: 39462524
Aims: We set out to explore associations between a 'mitral-specific' cardiac damage score (m-CDS) and survival outcomes in mitral regurgitation (MR) and compare the performance of the m-CDS and an...
8.
Strom J, Playford D, Stewart S, Strange G
JACC Adv
. 2024 Oct;
3(9):101176.
PMID: 39372458
Background: Identifying individuals with severe aortic stenosis (AS) at high risk of mortality remains challenging using current clinical imaging methods. Objectives: The purpose of this study was to evaluate an...
9.
Butcher S, Hirasawa K, Meucci M, Stassen J, Kuneman J, Pereira A, et al.
Eur Heart J Cardiovasc Imaging
. 2024 Jul;
25(12):1638-1648.
PMID: 38984693
Aims: To evaluate the prognostic implications of the left atrial reservoir strain-defined diastolic dysfunction (LARS-DD) grade in patients undergoing transcatheter aortic valve implantation (TAVI) for severe aortic stenosis (AS) and...
10.
Playford D, Schwarz N, Chowdhury E, Williamson A, Duong M, Kearney L, et al.
JACC Adv
. 2024 Jun;
2(4):100356.
PMID: 38938261
Background: Symptoms associated with severe aortic stenosis (AS) are used to guide management. Objectives: The purpose of this study was to examine the pattern of symptoms, comorbidities, and cardiac damage...